Triazolopurine derivative, pharmaceutical composition...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/14 (2006.01) A61K 31/505 (2006.01) A61K 31/675 (2006.01) C07F 9/6561 (2006.01)

Patent

CA 2326716

Disclosed is a triazolopurine derivative represented by the general formula: (see formula 1) wherein R1 and R2 represent the same groups as those described in the specification; and A represents a group: (see formula 2, 3 or 4) wherein R3 represents the same groups as those described in the specification. This compound is incorporated in a pharmaceutical composition because of its affinity to an adenosine A3 receptor, and is used as an adenosine A3 receptor antagonist or a remedy for asthma.

L'invention concerne des dérivés de triazolopurine représentés par la formule (1). Dans cette formule, R<1> et R<2> sont chacun définis dans le descriptif; A représente un groupe représenté par (a), (b) ou (c) (où R<3> est tel que défini dans le descriptif). Ces composés présentent une affinité pour un récepteur de l'adénosine A3. Une composition médicinale contenant n'importe lequel de ces composés est utilisée comme agent de compatibilisation de récepteur de l'adénosine A3 ou comme médicament contre l'asthme.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Triazolopurine derivative, pharmaceutical composition... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triazolopurine derivative, pharmaceutical composition..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolopurine derivative, pharmaceutical composition... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2053018

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.